Preliminary Program-at-a-Glance

Please note that this is a preliminary program and is subject to change. More details will be released soon. Stay tuned for updates.

For the latest information, please check back regularly.

Saturday, 29 August 2026
All DayMini-School of Influenza
Sunday, 30 August 2026
08:00-08:30Opening Remarks
08:30-10:30Opening Plenary Session I – Implementation
11:00-12:30ISRV Award Session
12:30-14:00Lunch/Networking
14:00-16:00Symposia Sessions:
Clinical Science: Optimizing Antiviral Utilization for Influenza
Implementation: Strategies to Address Vaccine Hesitancy in High-Risk Populations
Public Health: Measuring the Impact of Interventions
Virology & Pathogenesis: Influenza Virology
16:30-18:00Oral Abstract Sessions
18:00-19:30Exhibit Hall and Poster Session
Monday, 31 August 2026
08:00-10:00Plenary Session II – Public Health
10:00-10:45Award Presentation
11:15-12:30Oral Abstract Sessions
12:30-14:00Lunch/Networking
14:00-16:00Symposia Sessions:
Clinical Science: Diagnostics and Biomarkers of Influenza Infection
Implementation: Implementation Science to Drive Influenza Vaccines in LMICs
Public Health: Innovative Tools and Their Contributions to Public Health Strategies
Virology & Pathogenesis: Influenza Pathogenesis
16:30-18:00Oral Abstract Sessions
18:00-19:30Exhibitor Hall & Poster Sessions
Tuesday, 1 September 2026
08:30-10:30Plenary Session III – Clinical Science
11:00-12:30Oral Abstract Sessions
12:30-14:00Lunch/Networking
14:00-16:00Symposia Sessions:
Clinical Science: Respiratory Viruses in the Immunocompromised
Implementation: Manufacturing Strategies to Ensure Adequate Global Supply and Capacity of Influenza Vaccine
Public Health: Pandemic Preparedness
Virology & Pathogenesis: H5 Influenza
16:30-18:00Oral Abstract Sessions
18:00-19:30Exhibit Hall & Poster Sessions
Wednesday, 2 September 2026
08:00-10:00Plenary Session IV – Virology & Pathogenesis
10:30-12:00Oral Abstract Session
12:00-13:30Lunch/Networking
13:30-15:30Symposia Sessions:
Clinical Science: Trial Methodology to Address Public Health and Clinical Issues
Late Breaker Oral Abstract Session
Public Health: Evidence for Vaccine Policy
Virology & Pathogenesis: Next Generation Technology to Study Influenza
16:00-17:00Closing Plenary Session V

 

Questions about the Options XIII Conference?

Contact the Options XIII Conference planners at Options@ConferenceSolutionsInc.com or call 503-244-4294.